0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
about
Pediatric Atopic Dermatitis: A Review of the Medical ManagementTopical tacrolimus for atopic dermatitisCost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.The effects of treatment on itch in atopic dermatitisGuidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children.Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.Atopic eczema: what's new?A systematic review of the safety of topical therapies for atopic dermatitis.The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.Meta-analysis of tacrolimus ointment for atopic dermatitis in pediatric patients.Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use.Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.Update on the management of chronic eczema: new approaches and emerging treatment optionsOptimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate.What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.Topical corticosteroids and hospital length of stay in children with eczema herpeticum.Tacrolimus ointment in the management of atopic dermatitis.Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study.Eczema (atopic).Prescription Treatment Options.Non-Prescription Treatment Options.Atopic dermatitis: a review of topical nonsteroid therapy.Blinded side-to-side comparison of topical corticosteroid and tacrolimus ointment in children with moderate to severe atopic dermatitis
P2860
Q22065280-96817FAA-EF2A-4E15-9C8F-67B04B263236Q24186624-4624E261-1CD5-48BF-9F21-FC4BCB5B2168Q31096548-BC0C422F-F470-44A8-BC54-215970DFE243Q31149849-83C249B2-32B5-44CF-A387-DB894899B380Q34336696-DE996A8C-3F45-4BAC-A9A4-03FC683D72AAQ35077866-1139FD4E-C24A-41E6-9CB9-831F8F839F24Q36153370-E1C08846-DFE3-4339-BEFD-8B07F67E7251Q36222741-24A0F23E-F384-4506-9421-393BF98E9488Q36473293-B446E5E0-2CD6-4C4C-ADFA-000517FE2BFCQ36708358-F333A1A1-53FC-4010-93B5-07C84182BF69Q36940038-EBEC0907-83A6-4CE5-8F51-428481527A33Q37096190-29B7FBD2-B79F-48F9-AAA3-D432A2BBB6F3Q37327264-2D55DF33-E5DC-4A5E-B5E3-2EE441DED979Q37731539-232878FD-277E-40D1-927D-EDBDFBFD40A3Q37857682-F022FBD5-5377-4967-83C9-A3A7B89A6BE8Q37865056-D3BCE48E-5D29-43DB-8241-DC37A0498950Q38933737-73CD182C-8C9F-4554-8A91-B6DDB4D1DD93Q39541512-F5B509B8-DC56-4696-8228-37A9ED0A8408Q42081579-3E9969D2-D1EC-4462-861C-72104F55015CQ42633680-F669B77F-518B-402B-B741-E0558CCF07F0Q46721613-83B50FF4-DFD5-4078-A9C0-1637E4CC55C5Q50074353-49D009E2-B04F-4ECB-B90D-9FD203F6212BQ50074357-24933EAD-3022-4110-BF3C-962E4E6886A3Q52597622-49228E5B-E65B-42A4-B701-16804A6E3631Q57173891-841C2593-25FB-49F2-98B6-21FB563AF391
P2860
0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
0.03% Tacrolimus ointment appl ...... double-blind controlled trial.
@en
0.03% Tacrolimus ointment appl ...... double-blind controlled trial.
@nl
type
label
0.03% Tacrolimus ointment appl ...... double-blind controlled trial.
@en
0.03% Tacrolimus ointment appl ...... double-blind controlled trial.
@nl
prefLabel
0.03% Tacrolimus ointment appl ...... double-blind controlled trial.
@en
0.03% Tacrolimus ointment appl ...... double-blind controlled trial.
@nl
P2093
P2860
P1476
0.03% Tacrolimus ointment appl ...... double-blind controlled trial.
@en
P2093
C Bruijnzeel-Koomen
European Tacrolimus Ointment Group
F Cambazard
P2860
P304
P356
10.1046/J.1365-2133.2004.05782.X
P407
P577
2004-03-01T00:00:00Z